Reversal of Ballantyne syndrome by selective second-trimester fetal termination: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 45, Issue 4, 2000, Pages 360-362

  Heyborne, Kent D ^a   Chism, Denise M ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

Ballantyne syndrome; Fetal hydrops; Fetal termination, selective; Twins

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELIVERY; DISEASE ASSOCIATION; FEMALE; FETUS HYDROPS; HUMAN; PREECLAMPSIA; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SECOND TRIMESTER ABORTION; TWIN PREGNANCY;

EDEMA; FEMALE; HUMANS; HYDROPS FETALIS; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY REDUCTION, MULTIFETAL; PREGNANCY TRIMESTER, SECOND; PROGNOSIS; SYNDROME; TWINS;

EID: 0034006603     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Magann EF, Bass D, Chauhan SP, et al: Antepartum corticosteroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-1153
2. Carbillon L, Oury JF, Guerin JM, et al: Clinical biological features of Ballantyne syndrome and the role of placental hydrops. Obstet Gynecol Surv 1997;52:310-314
3. Duthie SJ, Walkinshaw SA: Parvovirus associated fetal hydrops: Reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol 1995;102:1011-1013
4. Evans MI, Goldberg JD, Dommergues M, et al: Efficacy of second-trimester selective termination for fetal abnormalities: International collaborative experience among the world's largest centers. Am J Obstet Gynecol 1994;171:90-94